These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 2835828

  • 1. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W.
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [Abstract] [Full Text] [Related]

  • 2. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT, Allen GP.
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [Abstract] [Full Text] [Related]

  • 3. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F, Nowotny N, Hofer A.
    Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
    [Abstract] [Full Text] [Related]

  • 4. Equine herpesvirus.
    Vet Rec; 1989 May 13; 124(19):519. PubMed ID: 2547266
    [No Abstract] [Full Text] [Related]

  • 5. [Relevance of infection with equine herpesvirus 1 (EHV-1) in a German thoroughbred stud: vaccination, abortion and diagnosis].
    Schröer U, Lange A, Glatzel P, Ludwig H, Borchers K.
    Berl Munch Tierarztl Wochenschr; 2000 Feb 13; 113(2):53-9. PubMed ID: 10726362
    [Abstract] [Full Text] [Related]

  • 6. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F, Rossmanith W, Nowotny N, Pallan C, Möstl K, Lussy H.
    Vet Q; 1990 Apr 13; 12(2):80-6. PubMed ID: 2163560
    [Abstract] [Full Text] [Related]

  • 7. Vaccines for EHV1 abortion.
    Mitchell D.
    Vet Rec; 1983 Mar 19; 112(12):285. PubMed ID: 6302971
    [No Abstract] [Full Text] [Related]

  • 8. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):47-57. PubMed ID: 16580075
    [Abstract] [Full Text] [Related]

  • 9. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R, Goodridge D, Denyer MS.
    Vet Rec; 1984 Apr 14; 114(15):369-74. PubMed ID: 6328728
    [Abstract] [Full Text] [Related]

  • 10. Foetal and neonatal foal losses on equine herpesvirus type 1(EHV-1) infected farms before and after EHV-1 vaccination was introduced.
    Frymus T, Kita J, Woyciechowska S, Ganowicz M.
    Pol Arch Weter; 1986 Apr 14; 26(3-4):7-14. PubMed ID: 2830601
    [Abstract] [Full Text] [Related]

  • 11. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.
    Vet Immunol Immunopathol; 2005 May 01; 105(1-2):47-57. PubMed ID: 15797474
    [Abstract] [Full Text] [Related]

  • 12. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR, Studdert MJ.
    Am J Vet Res; 1984 Oct 01; 45(10):1947-52. PubMed ID: 6208822
    [Abstract] [Full Text] [Related]

  • 13. Vaccination of mares against equine herpesvirus-1.
    Pickles AC.
    Vet Rec; 1992 Feb 22; 130(8):167-8. PubMed ID: 1314446
    [No Abstract] [Full Text] [Related]

  • 14. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.
    Vet Immunol Immunopathol; 2006 May 15; 111(1-2):67-80. PubMed ID: 16476488
    [Abstract] [Full Text] [Related]

  • 15. Towards a vaccine against equine herpesvirus 1.
    Sabine M, Whalley JM.
    Aust Vet J; 1989 Dec 15; 66(12):403-4. PubMed ID: 2559691
    [No Abstract] [Full Text] [Related]

  • 16. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH.
    Vaccine; 2006 Mar 06; 24(10):1490-500. PubMed ID: 16269205
    [Abstract] [Full Text] [Related]

  • 17. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA, Mock RE, Lock TF.
    Am J Vet Res; 1980 Jul 06; 41(7):994-6. PubMed ID: 6254412
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.
    Vaccine; 2006 Apr 24; 24(17):3636-45. PubMed ID: 16513225
    [Abstract] [Full Text] [Related]

  • 19. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C, Lämmer M, Wagner B, Osterrieder N, Damiani AM.
    Vet Microbiol; 2012 Nov 09; 160(1-2):9-16. PubMed ID: 22633483
    [Abstract] [Full Text] [Related]

  • 20. [Equine rhinopneumonitis virus infection in horses. II (author's transl)].
    Dijkstra RG, de Boer GF.
    Tijdschr Diergeneeskd; 1976 May 01; 101(9):494-7. PubMed ID: 178066
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.